安大略省骨折筛查与预防项目的成本效用分析
该研究从加拿大安大略省公共医疗支付方视角,采用马尔可夫模型模拟71岁起脆性骨折患者,比较骨折联络服务项目FSPP与常规照护的终生成本效用;
要点
- FSPP较常规照护终生成本低277加元且多获0.018 QALY。
- FSPP对脆性骨折患者终生具有成本效果。
核心结论
- FSPP相对于常规照护在脆性骨折患者终生时间范围内具有成本效果。
研究设计与样本
- 采用状态转移马尔可夫模型进行成本效用分析,模拟71岁起脆性骨折患者队列,参数来自已发表文献和FSPP。
主要发现
- FSPP预期成本比常规照护低277加元,预期效果高0.018 QALY。
关键数值与推荐
- 成本以2018年加拿大元计,终生时间范围,年贴现率1.5%。
- 健康结局包括后续股骨近端、椎体、肱骨近端和桡骨远端骨折。
临床怎么用
- 可为政策制定者决定是否扩大FSPP至更多医院或启动类似项目提供价值量化依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Fracture Screening and Prevention Program (FSPP), a fracture liaison service (FLS), was implemented in the province of Ontario, Canada, in 2007 to prevent recurrent fragility fractures and to improve post-fracture care. The objective of this analysis was to determine the cost-effectiveness of the current model of the FSPP compared with usual care (no program) from the perspective of the universal public health-care payer (Ontario Ministry of Health and Long-Term Care [MOHLTC]), over the lifetime of older adults who presented with a fragility fracture of the proximal part of the femur, the proximal part of the humerus, or the distal part of the radius and were not taking medications to prevent or slow bone loss and reduce the risk of fracture (bone active medications). METHODS: We developed a state-transition (Markov) model to conduct a cost-effectiveness analysis of the FSPP in comparison with usual care. The model simulated a cohort of patients with a fragility fracture starting at 71 years of age. Model parameters were obtained from published literature and from the FSPP. Quality-adjusted life-years (QALYs) and costs in 2018 Canadian dollars were predicted over a lifetime horizon using a 1.5% annual discount rate. Health outcomes included subsequent proximal femoral, vertebral, proximal humeral, and distal radial fractures. Scenario and subgroup analyses were reported. RESULTS: The FSPP had lower expected costs ($277 less) and higher expected effectiveness (by 0.018 QALY) than usual care over the lifetime horizon. Ninety-four percent of the 10,000 Monte Carlo simulated incremental cost-effectiveness ratios (ICERs) demonstrated lower costs and higher effectiveness of the FSPP. CONCLUSIONS: The FSPP appears to be cost-effective compared with usual care over a lifetime for patients with fragility fracture. This information may help to quantify the value of the FSPP and to assist policy-makers in deciding whether to expand the FSPP to additional hospitals or to initiate similar programs where none exist. LEVEL OF EVIDENCE: Economic and Decision Analysis Level II. See Instructions for Authors for a complete description of levels of evidence.
引用
- Saunders H, Sujic R, Bogoch ER, et al. Cost-Utility Analysis of the Ontario Fracture Screening and Prevention Program. J Bone Joint Surg Am. 2021. PMID: 33764937. doi:10.2106/JBJS.20.00795
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。